Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past 24 hours
Any time
Past hour
Past 7 days
Past 30 days
Most recent
Best match
15h
on MSN
Kisqali wins FDA nod for breast cancer treatment: Dosage, effectiveness and side effects of the breakthrough drug
The US FDA has approved Kisqali (ribociclib) for treating early-stage breast cancer in combination with hormone therapy. It ...
Medscape
23h
FDA OKs Adjuvant Ribociclib in Earlier Stage Breast Cancer
Unlike rival CDK 4/6 inhibitor abemaciclib, patients don't need to be lymph-node positive to receive ribociclib after surgery ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Kentucky judge fatally shot
FCC chair denies Trump call
To visit US next week
Cancels appearance w/ Duda
Retires after 17 seasons
Boy kills bear, saves father
Man charged for threats
Hold campaign event in MI
To get a second moon
Ban called for in TX schools
Families lose appeal
Collapse hazard recall
Vows to remain in race
PGA welcomes LIV players
160M euros to Ukraine
Joins Motion Picture Assn.
NYC subway joyride arrest
Gun case sentencing delay
Overdose deaths drop in US
Hails economic progress
FTC on privacy controls
COVID, Wuhan market link
To receive Holbrooke award
EU warns Apple
Existing home sales drop
Dow, S&P hit record highs
US jobless claims fall
Brazil threatens daily fines
Israel strikes Hezbollah
UN backs Palestine
Makes MLB history
Related topics
Breast cancer
Kisqali
Food and Drug Administration
HR+
Feedback